Glen Eagle Advisors, LLC
- SEC CIK
- 0002029317
- Latest filing
- Aug 14, 2026
TEVA holding history
Teva Pharmaceutical Industries Ltd in every 13F filed by Glen Eagle Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TEVA overviewAll 13F holders of TEVAFull Q2 2026 holdings
- Shares (Q2 2026)
- 200
- Value
- $6.78K
- % of portfolio
- <0.1%
- Quarters held
- 16
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 200 | $6.78K | <0.1% | +40+25.0% | Added | Holders |
| Q1 2026 | 160 | $4.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 160 | $4.99K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 160 | $3.23K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 160 | $2.68K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 160 | $2.46K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 160 | $3.53K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 160 | $2.88K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 160 | $2.60K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 160 | $2.26K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 160 | $1.67K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 160 | $1.63K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 160 | $1.21K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 160 | $1.42K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 160 | $1.46K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 160 | $1.29K | <0.1% | +160 | New | Holders |